NQO1 and colonic neoplasm: An indolequinone-diazeniumdiolate was reported to exhibit the targeting ability once activated by NAD(P)H: quinone oxidoreductase 1 (DT-diaphorase), a bioreductive enzyme that is overexpressed in colon cancer [141].